Intriguingly, more recent studies have also identified the high expression of FSP1 in immune suppressive T and myeloid cells, which suppress the immune response, and deleting FSP1 in non‐cancer cells elevated survival rate and change immune landscape, supporting the pro‐tumour effect of FSP1.56 The gene discussed is S100A4; the disease is cancer.